A Prospective Cohort Study on the usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) and TIC analysis in Pancreatic neuroendocrine tumors.

A Prospective Cohort Study on the usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) and TIC analysis in Pancreatic neuroendocrine tumors. - usefulness of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) and TIC analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027698

Enrollment

Registered

2017-06-09

Start date

2011-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic neuroendocrine tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients depicted Pancreatic mass using conventional EUS. 2)ECOG performance status = 0-1 3)Patients with adequate function of major organs 4)Patients who have provided written informed consent for participation in this study.

Exclusion criteria

Exclusion criteria: 1)The patients who had an allergy to the contrast agent, Sonazoid. 2)The patients who had severe or uncontrolled concomitant systemic disorder.

Design outcomes

Primary

Measure	Time frame
To assess the diagnostic ability of CH-EUS and TIC analysis in malignancy evaluation of pancreatic tumors.	—

Countries

Japan

Contacts

Public Contactsimon takada

Okayama university hospital Gastroenterology and hepatology

riberu4@gmail.com086-235-7219

Outcome results